Pricing Log in Create free account
Friday 6 November 2026 Export NTRA’s income statement to Excel — free account

Natera, Inc.

NTRA Healthcare Diagnostics & Research

Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.

Revenue
+34.1%
EPS
+34.4%
Free cash flow
−85.8%
Total debt
−0.06%

Quarter to September 2026, against a year earlier

312.29 51.47 −14.15%
Market cap
$52.4B
P/E
0.0×
Fwd P/E
−289×
Dividend yield
—
F-score
6/9
Altman Z
26.84
Beneish M
−2.17
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Natera, Inc. (NTRA) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Natera, Inc. (NTRA) trades at a EV/Sales of 17.9×. Over the past ten years it has ranged from 0.0× (February 2016) to 24.5× (February 2021); the current reading is higher than 92% of that period. That is above the Diagnostics & Research industry median of 5.2× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 13.3× 17.68%
FY2024 11.3× 84.88%
FY2023 6.1× 53.92%
FY2022 4.0× (68.51%)
FY2021 12.6× (35.05%)
FY2020 19.4× 189.17%
FY2019 6.7× 123.49%
FY2018 3.0× 23.47%
FY2017 2.4× (3.87%)
FY2016 2.5× 318.45%

Quarterly newest first

Period EV/Sales Change
Sep 2026 20.2× 43.42%
Jun 2026 14.1× 27.86%
Mar 2026 11.0× (16.93%)
Dec 2025 13.3× 31.25%
43 more quarters

Against its own ten years

Low 0.0× High 24.5×
Ten-year median 6.3×
Current reading's percentile 92

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.4×
DGX Quest Diagnostics Incorporated compare 2.8×
IQV IQVIA Holdings Inc. compare 3.3×
A Agilent Technologies, Inc. compare 6.8×
ILMN Illumina, Inc. compare 7.2×
MTD Mettler-Toledo International, Inc. compare 8.7×
WAT Waters Corporation compare 8.7×
IDXX IDEXX Laboratories, Inc. compare 11.3×
NTRA Natera, Inc. 17.9×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on NTRA